Diabetes classification/diagnosis and Hypoglycemia Flashcards

1
Q

Etiologic classification of DM

A

I. Type I diabetes
II. Type II diabetes
III. Gestational diabetes
IV. Other specific types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

I. Type I diabetes (3)

A
  • beta cell destruction, usually leading to absolute insulin deficiency
  • immune mediated, idiopathic or LADA (latent autoimmune diabetes in adults)
  • markers of immune destruction (ICAs, GAD65, IA-2, IAAs, Xinc ZnT8)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Staging of type I diabetes

A
  1. Stage 1 - autoimmunity, normoglycemia, pre-symptomatic, multiple autoAb, no IGT (impaired glucose tolerance) or IFG (impaired fasting glucose)
  2. Stage 2 - autoimmunity, dysglycemia, pre-symptomatic, multiple autoAb, FPG (5.6-6.9), 2h-PG (7.8-11.0), A1c (5.7-6.4%)
  3. Stage 3 - new onset hyperglycemia, symptomatic, clinical symptoms, diabetes by standard criteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

II. Type II diabetes (4)

A
  • progressive loss of adequate beta cell insulin secretion frequently on the background of insulin resistance
  • most patients –> overweight or obese
  • goes undiagnosed for many years because hyperglycemia develops slowly
  • risk increases with age, obesity, lack of physical activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

III. Gestational diabetes (4)

A
  • diabetes diagnosed in the second or third trimester of pregnancy
  • indicative of underlying beta-cell dysfunction
  • increased risk for later development of diabetes
  • life long screening for pre-diabetes is necessary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Monogenic diabetes syndrome (2)

A
  • all children diagnosed with diabetes in the first 6 months of life
  • immediate genetic testing should be done
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Criteria for the diagnosis of diabetes

A
FGP 7.0 mmol/L or higher 
                   OR 
2h PG 11.1 mmol/L or higher during OGTT 
                   OR 
A1C 6.5% (48 mmol/mol) or higher 
                  OR 
in a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose of 11.1 mmol/l or higher 

two abnormal tests results are required to make the diagnosis!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Criteria defining pre-diabetes

A
FPG 5.6-6.9 mmol/L 
                OR
2h PG 75h OGTT 7.8-11.0 mmol/L
                OR 
A1C 5.7-6.4% (39-47 mmol/mol)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diagnosis of gestational diabetes mellitus

A
  1. Test plasma glucose at the first prenatal visit
    - FPG 5.1 mmol/ or higher - confirm diagnosis
    - FPG 6.1-6.9 mmol/ - perform OGTT
  2. Test for gestational DM at 24-28 weeks of gestation
    - Fasting 5.1-6.9 mmol/l
    - 1h - 10.0 mmol/l or higher
    - 2h 8.5-11.0 mmol/l
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When to test women for gestational DM?

A
  • test women for pre-diabetes or diabetes at 4-12 weeks post-partum
  • women with a history of gestational DM should have life long screening for the development of diabetes or prediabetes at least every 3 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Islets of Langerhans are composed of…?

A

Beta cells - insulin
Alpha cells - glucagon
Delta cells - somatostatin
PP cells - pancreatic polypeptide

blood flow
beta –> alpha –> delta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fasting plasma glucose levels

  • lower limit
  • lower values may occur
A
  • 3.9 mmol/L
  • prolonged fasting, strenuous exercise, pregnancy

men - doest not fall below 3 mmol/L
women - doest not fall below 1.7 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Response to hypoglycemia (4)

A
  1. decrease insulin secretion
  2. increase glucagon secretion
  3. increase epinephrine secretion
  4. increase cortisol and growth hormone secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Classification of hypoglycemia in people with DM

A

Level 1 –> glucose <70 mg/dL (<3.9 mmol/L) - lower limit
-eat carbs, avoid critical tasks, repeat glucose measurements

Level 2 –> glucose <54 mg/dL (<3.0 mmol/L)
-immediate and long term consequences

Level 3 –> severe, altered physical and mental states, required assistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Does the risk of hypoglycemia increase or decreases with an increase in HbA1c?

A

increase HbA1c –> decrease the risk of hypoglycemia BUT increases the risk of DM complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Etiology of hypoglycemia

A
  1. Seemingly well individual - endogenous hyperinsulinism (insulinoma, beta cell disorders, etc…), accidental, malicious hypoglycemia
  2. Medicated individuals - drugs, critical illnesses, hormone deficiency, non-islet cell tumor
17
Q

Insulinoma (4)

A
  • rare pancreatic islet cell tumor
  • most are solitary and benign
  • manifest as fasting hypoglycemia
  • sporadic or associated with multiple endocrine neoplasia type 1 (MEN1)
18
Q

Whipple’s triad

A

-criteria that suggest a patient’s symptoms result from hypoglycemia that may indicate insulinoma

  1. Specific symptoms
  2. Low plasma glucose concentration when symptoms are present
  3. Relief symptoms after the plasma glucose level is raised
19
Q

Insulinoma

-symptoms

A
Autonomic response (adrenergic symptoms) - glucose <3.1 mmol/l
-sweating, weakness, tachycardia, palpitations, tremor, paresthesia, hunger, nervousness 

Neuroglycopenia - glucose <2.8 mmol/l
-irritability, confusion, seizure, visual disturbance, loss of consciousness, transient focal neurologic defects

20
Q

Insulinoma

  • diagnosis (3)
  • treatment (4)
A
  • must differentiate between insulin mediated and non-insulin mediated fasting hypoglycemia
  • perform a 72h fast test
  • abnormally high serum insulin, pro-insulin and C-peptide
  • operation, radiation or chemotherapy
  • medications: diazoxide (inhibit insulin release), verapamil and phenytoin (inhibit insulin release), somatostatin receptor analogs - ocreotide, lancreotide
21
Q

Hypoglycemia - risk factors (9)

A
  • longer duration of diabetes
  • older age
  • erratic timing of meals
  • exercise
  • alcohol ingestion
  • chronic kidney disease
  • malnutrition
  • lower levels of glycemia, achieved with medications
  • hypoglycemia associated autonomic failure
22
Q

Hypoglycemia associated autonomic failure (3)

A
  • type 1 and longstanding type 2 DM
  • defective glucose counter regulation –> inability to suppress insulin secretion, attenuated response of glucagon and epinephrine
  • partly reversible
23
Q

Classification of severity of hypoglycemia

A

Severe - administer carbs, glucagon and others
Documented symptomatic - <3.9 mmol/L
Asymptomatic - <3.9 mmol/L
Probable symptomatic - not accompanied by measurement of glucose level
Pseudo hypoglycemia - typical symptoms, <3.9 mmol/L

24
Q

Hypoglycemia

-treatment

A
  1. 15-20grams of fast-acting carbs
  2. Retest after 15min
  3. If glucose remains <3.9 mmol/L, repeat 1st step
  4. Ingest long-acting carbs to prevent recurrence

if severe

  • if IV not available –> glucagon 0.5-1mg –> not effective if glycogen stores are depleted
  • IV - 25g of 50% glucose
25
Q

Acute changes expected in hyperglycemia (3)

A
  • Increased CRP
  • Increased WBC
  • Reduced eGFR